688553 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Sichuan Huiyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. It offers anti-tumor injections such as pemetrexed disodium, azacitidine, docetaxel, zoledronic acid, doxorubicin hydrochloride, oxaliplatin, and epirubicin. The company was founded by Zhao Ding, Xiao Peng Wang and Bo Yu on October 12, 2010 and is headquartered in Neijiang, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688553 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company